Week 22 in the war on cancer. Could have been much better. Here we are:
-On Monday we learned, as we suspected, that there is also progression in the lungs. We hence have both progression in the brain and in the lungs. The good news is that no new lesions can be seen on the scans.
-As Dyanne has tested positive for the common resistance mutation T790M, the plan is to switch to a third generation tyrisine kinase inhibitor called Tagrisso (AZD9291). We hope to get this on compassionate use/extended access and we hope to get it soon.